Alpha Tau destroyed #JPM26 with data

One quick note on Alpha Tau that I think needs more focus is the results they shared on systemic immune system retraining. Let me break it down in simple speak: the local application of alpha radiation is demonstrating repeatedly the systemic elimination of tumors unassociated with the treated area. I’ll ask politely that you reread that last sentence one more time since your financial future depends on it. What this means is that the heroic ability demonstrated by Alpha Tau in the effective treatment and life extension of the hardest to treat tumors is not the big picture. That’s a mouth watering $5B valuation company sitting at $600M today. The big picture is that DaRTS, based on their reeducation of the immune system to eliminate tumors, will wind up a very unheroic first line of attack against all solid tumors so nobody has to get to the “hero needs a miracle” stage. That means you take whatever billion dollar valuation you had for $DRTS and you add a zero. If you’re not in $DRTS after yesterday’s #JPM26 presentation - and Cathie Woods placing the first institutional order last night - are you really a biotech investor or do you just get dopamine high from PDUFA filings?